Hepatitis C Information - Coley Pharmaceutical Group Reports Fourth Quarter and Full Year ...

Coley Pharmaceutical Group Reports Fourth Quarter and Full Year ...
MSN Money - Feb 23, 2006... being evaluated alone and in combinations with drugs which comprise the current standard of care for the treatment of chronic Hepatitis C infection in subjects ...

Transgene: 2005, A Year of Significant Achievements Paving the Way ...
CNW Telbec (Communiqu s de presse), Canada - Feb 22, 2006... Additionally, Transgene secured a EUR 1.3 million government grant for its TG 4040 (MVA-HCV) therapeutic vaccine programme against chronic hepatitis C infection ...

Tampa Firm's Medication Has Enormous Potential As Hepatitis ...
International News Service, Australia - Feb 24, 2006... to-newborn. --Hepatitis C: Infection is primarily passed through blood exposure, rarely through sex or mother-to-newborn. There ...

Peregrine Pharmaceutical Will Deliver Hepatitus C Phase I Safety ...
Medical News Today (press release), UK - Feb 22, 2006... Dr. McHutchison has published widely in the field of liver diseases and is the author of numerous articles and book chapters on chronic hepatitis C infection. ...

Human Genome Sciences Reports Positive Interim Results of Phase 2 ...
Yahoo! News (press release) - Mar 14, 2006... treatment of chronic hepatitis C. Hepatitis C infection is an inflammation of the liver caused by the hepatitis C virus. It is the most ...